Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...

National Eye Institute (NEI) scientists have found that the way the retina metabolizes glucose directly controls which genes get switched on and off in light-sensing photoreceptors. The findings ...

The intricate relationship between bio-energy transport and protein molecule interactions in retinal cells has emerged as a focal point in contemporary research. Fundamental to this process is the ...

New preclinical data presented demonstrate the candidates’ therapeutic potential as innovative treatments for retinal vascular diseases, such as DME and wAMD, providing potent and long-lasting ...

Please provide your email address to receive an email when new articles are posted on . EXN407 met primary endpoints of safety and tolerability and also demonstrated decreases in vascular leakage and ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." The human eye is a wonder of evolution, but it’s also host to a variety of maladies that can make a once ...

Encinitas, California--(Newsfile Corp. - February 11, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it received regulatory approval to initiate KLARITY, ...

Scientists have for the first time looked deep into the protein structure that may determine our vision - and discovered that it is much more dynamic than previously thought. RBP3 not only changes its ...

Please provide your email address to receive an email when new articles are posted on . BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Bart Leroy, MD, PhD, speaks ...